Close Menu

lab-on-a-chip

DNANudge is developing an at-home testing kit, based on DNAe's semiconductor technology, to screen around 50 SNPs associated with nutrition and metabolism.

Drop to Drop

Not every drop of blood is the same, according to researchers from Rice University.

The San Diego-based firm will use the Series C investment and convertible debt to land regulatory clearance for its cancer treatment response assay.

NEW YORK (GenomeWeb) – Contract research organization Nanosyn today announced a multiyear research service agreement to provide its microfluidics screening and profiling capabilities to Forma Therapeutics.

NEW YORK (GenomeWeb News) – A consortium of European research institutions and private partners will use €5.3 million ($7.4 million) in funding to develop a microfluidics-based lab-on-a-chip device to identify and measure the concentration of circulating tumor cells in blood, one of the partners,

NEW YORK (GenomeWeb News) – The Johns Hopkins University and Imec today announced a collaboration to "expand healthcare applications" for silicon nanotechnology.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Agilent Technologies today said that it will collaborate with the US Food and Drug Administration on food testing applications.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Siemens has put its lab-on-a-chip technology up for sale.

ADA will develop the technology to identify biological hazards in complex matrices.

Pages

University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.

A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.

Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.

In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.